Bruker Cellular Analysis Competitors and Similar CompaniesClear all
Bruker Cellular Analysis's competitors and similar companies include Sangamo Therapeutics, GenScript, Crescendo Biologics and Spark Therapeutics.
 Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. |  Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. |  GenScript Genscript Biotech is a biotech company focusing on early drug discovery and development services. |  Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. | ||
Founding Date | Founding Date 2011 | Founding Date 1995 | Founding Date 2002 | Founding Date 2007 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Nanjing, CN HQ Tokyo, JP Seoul, KR Rijswijk, NL Singapore, SG Oxford, GB Piscataway, US | Locations Babraham, GB HQ | Locations Philadelphia, US HQ |
Employees | Employees 1391% decrease | Employees 35417% increase | Employees 5,568 | Employees 12 | Employees 36817% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 416.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $959.5m (FY, 2025) | Revenue (est.) £7.5m (FY, 2018) | Revenue (est.) $64.7m (FY, 2018) |
Cost of goods | Cost of goods $24.8m (FY, 2022) | Cost of goods N/A | Cost of goods $332.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $53.8m (FY, 2022) | Gross profit N/A | Gross profit $650.8m (FY, 2025) | Gross profit £7.5m (FY, 2018) | Gross profit N/A |
Net income | Net income ($98m) (FY, 2022) | Net income ($122.9m) (FY, 2025) | Net income ($532.4m) (FY, 2025) | Net income (£1.8m) (FY, 2018) | Net income ($78.8m) (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised $ 124.7m | Total funding raised $ 74.2m | Total funding raised N/A | Total funding raised $ 116.2m | Total funding raised $ 122.8m |
For sources of this data, please see the company profile
View Company Profiles
Sangamo Therapeutics
HQ
Brisbane, US
Employees
354↑ 17% increase
Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies.
View companyGenScript
HQ
Nanjing, CN
Employees
5,568
Genscript Biotech is a biotech company focusing on early drug discovery and development services.
View companyCrescendo Biologics
HQ
Babraham, GB
Employees
12
Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies.
View company
Spark Therapeutics
HQ
Philadelphia, US
Employees
368↑ 17% increase
Spark Therapeutics is a gene therapy company.
View company